More importantly, we showed that DNA methylation was associated with alternative splicing and 5-Aza-CdR was able to change the exon-skipping in EZH2. This study provides valuable information on how demethylation drugs affect bladder cancer cells, thus shedding light on ongoing and future clinical trials that evaluate demethylation drugs. The gene discussed is EZH2; the disease is urinary bladder cancer.